tetano
Editor, Senior Moderator
J Clin Virol
. 2021 Dec 1;146:105050.
doi: 10.1016/j.jcv.2021.105050. Online ahead of print.
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
Fang Fang Li[SUP] 1 [/SUP], Aaron Liu[SUP] 2 [/SUP], Ebrima Gibbs[SUP] 3 [/SUP], Guadalein Tanunliong[SUP] 1 [/SUP], Ana Citlali Marquez[SUP] 4 [/SUP], Soren Gantt[SUP] 5 [/SUP], Hans Frykman[SUP] 6 [/SUP], Mel Krajden[SUP] 7 [/SUP], Muhammad Morshed[SUP] 7 [/SUP], Natalie A Prystajecky[SUP] 7 [/SUP], Neil Cashman[SUP] 6 [/SUP], Inna Sekirov[SUP] 7 [/SUP], Agatha N Jassem[SUP] 8 [/SUP]
Affiliations
Abstract
Background: Multiplex immunoassays capture a comprehensive profile of the humoral response against SARS-CoV-2 and human endemic coronaviruses. We validated a multiplex panel (V-PLEX Panel 2) from Meso Scale Diagnostics targeting antibodies against nine coronavirus antigens. Performance was compared against alternative single- and multi-antigen immunoassays.
Methods: Sera collected for clinical or public health testing from 2018 to 2020 (n = 135) were used to compare all tested platforms, and inter-test agreement was assessed by Cohen's kappa coefficient. Sample category (positive/negative) was assigned based on collection date relative to the index case in Canada, and SARS-CoV-2 PCR and serology results. 117 out of the 135 samples (31 positive, 86 negative) were assigned a category and were used to calculate sensitivity and specificity, with MSD's test results based upon manufacturer-set cut-offs.
Results: We observed SARS-CoV-2 target sensitivities of 100% and specificities >94% for all antigens (RBD, Nucleocapsid, Spike) in V-PLEX Panel 2. When targets were combined, we found a SARS-CoV-2 sensitivity of 100% and specificity of 98.8% with no difference in performance compared to clinical assays, and Cohen's kappa ranging from 0.798 to 0.945 compared to surface plasmon resonance imaging (SPRi). Quantitative measurements of antibodies against the Spike protein of endemic human coronaviruses were concordant with SPRi.
Conclusion: Meso Scale Diagnostics' V-PLEX Coronavirus Panel 2 allows for highly sensitive and specific detection of anti-coronavirus IgG, and is concordant with other serological assays for detection of antibodies against SARS-CoV-2 and the endemic human coronaviruses, making it a good tool for humoral response characterization after both infection and vaccination.
Keywords: COVID-19; Human coronavirus; Immunoassays; Multiplex serology; SARS-CoV-2.
. 2021 Dec 1;146:105050.
doi: 10.1016/j.jcv.2021.105050. Online ahead of print.
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
Fang Fang Li[SUP] 1 [/SUP], Aaron Liu[SUP] 2 [/SUP], Ebrima Gibbs[SUP] 3 [/SUP], Guadalein Tanunliong[SUP] 1 [/SUP], Ana Citlali Marquez[SUP] 4 [/SUP], Soren Gantt[SUP] 5 [/SUP], Hans Frykman[SUP] 6 [/SUP], Mel Krajden[SUP] 7 [/SUP], Muhammad Morshed[SUP] 7 [/SUP], Natalie A Prystajecky[SUP] 7 [/SUP], Neil Cashman[SUP] 6 [/SUP], Inna Sekirov[SUP] 7 [/SUP], Agatha N Jassem[SUP] 8 [/SUP]
Affiliations
- PMID: 34883405
- DOI: 10.1016/j.jcv.2021.105050
Abstract
Background: Multiplex immunoassays capture a comprehensive profile of the humoral response against SARS-CoV-2 and human endemic coronaviruses. We validated a multiplex panel (V-PLEX Panel 2) from Meso Scale Diagnostics targeting antibodies against nine coronavirus antigens. Performance was compared against alternative single- and multi-antigen immunoassays.
Methods: Sera collected for clinical or public health testing from 2018 to 2020 (n = 135) were used to compare all tested platforms, and inter-test agreement was assessed by Cohen's kappa coefficient. Sample category (positive/negative) was assigned based on collection date relative to the index case in Canada, and SARS-CoV-2 PCR and serology results. 117 out of the 135 samples (31 positive, 86 negative) were assigned a category and were used to calculate sensitivity and specificity, with MSD's test results based upon manufacturer-set cut-offs.
Results: We observed SARS-CoV-2 target sensitivities of 100% and specificities >94% for all antigens (RBD, Nucleocapsid, Spike) in V-PLEX Panel 2. When targets were combined, we found a SARS-CoV-2 sensitivity of 100% and specificity of 98.8% with no difference in performance compared to clinical assays, and Cohen's kappa ranging from 0.798 to 0.945 compared to surface plasmon resonance imaging (SPRi). Quantitative measurements of antibodies against the Spike protein of endemic human coronaviruses were concordant with SPRi.
Conclusion: Meso Scale Diagnostics' V-PLEX Coronavirus Panel 2 allows for highly sensitive and specific detection of anti-coronavirus IgG, and is concordant with other serological assays for detection of antibodies against SARS-CoV-2 and the endemic human coronaviruses, making it a good tool for humoral response characterization after both infection and vaccination.
Keywords: COVID-19; Human coronavirus; Immunoassays; Multiplex serology; SARS-CoV-2.